Please provide your email address to receive an email when new articles are posted on . Remote reprogramming for implantable cardiac devices was associated with an improvement in clinic workflow.
Asgard Therapeutics is developing off-the-shelf yet personalized therapies by recreating immune-cell fates in vivo. The biotech is pioneering an immuno-oncology modality that reprograms tumor cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results